Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia
NCT02526121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2016-08-30
Summary
The purpose of this study is to evaluate the effect of iron depletion with phlebotomies on blood triglyceride concentration, in subjects with hypertriglyceridemia and iron overload, compared with a dietary intervention alone.
All subjects in this study will follow dietary and lifestyle counseling in a period of 3 months.
A randomized group will receive phlebotomies every 3 weeks in this period.
Conditions
- Hyperferritinemia
- Hypertriglyceridemia
Interventions
- PROCEDURE
-
Phlebotomy
Volume of 400 mL every 3 weeks, 3 times.
- BEHAVIORAL
-
Dietary and lifestyle counseling.
Dietary and lifestyle counseling.
Sponsors & Collaborators
-
Instituto Aragones de Ciencias de la Salud
lead OTHER_GOV
Principal Investigators
-
Fernando Civeira, MD, PhD · Unidad de Lípidos/ Laboratorio de Investigación Molecular; Hospital Universitario Miguel Servet; Instituto Aragonés de Ciencias de la Salud (Zaragoza, Spain)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Iron Depletion and Replacement in Blood Donors
NCT01752413 ·Status: COMPLETED ·Phase: NA
-
Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
NCT04779593 ·Status: RECRUITING ·Phase: NA
-
Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency
NCT04139265 ·Status: COMPLETED
-
Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19
NCT04746066 ·Status: RECRUITING
-
Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome
NCT02262312 ·Status: COMPLETED
-
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
NCT01911871 ·Status: COMPLETED
-
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
NCT00202436 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Hemochromatosis
NCT00007150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge
NCT04920045 ·Status: TERMINATED ·Phase: NA
-
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
NCT05864170 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
NCT00069862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload
NCT00560820 ·Status: COMPLETED ·Phase: PHASE1
-
Thrombin Generation in Beta-thalassemia Major
NCT04962984 ·Status: UNKNOWN ·Phase: NA
-
Determination of Iron Absorption and Losses in People Living at High Altitude to Investigate the Requirements in This Population Group Using a Newly Developed Technique
NCT07142590 ·Status: RECRUITING ·Phase: NA
-
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
NCT00800761 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload
NCT01186419 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
NCT05693909 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
NCT01039636 ·Status: COMPLETED ·Phase: PHASE1
-
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
NCT02173951 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women
NCT01374776 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients
NCT05355766 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
NCT00000595 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3